LPCN: Lipocine Inc. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
3 open-market buys totaling $82K and 0 sales totaling - in the last 180 days.
Insider buys
| Score | Ticker | Company | Insider | Role | Trade date | Value | Holding + | Cluster |
|---|---|---|---|---|---|---|---|---|
| 28 | LPCN | Lipocine Inc. | Higuchi John W. | Director | 2026-09-30 | $36K | 7% | |
| 21 | LPCN | Lipocine Inc. | Higuchi John W. | Director | 2026-09-29 | $19K | 4% | |
| 27 | LPCN | Lipocine Inc. | Higuchi John W. | Director | 2026-09-28 | $27K | 6% |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.